Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high…
Zantac Heartburn Medication
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication Zantac exposes users to unsafe levels of the carcinogen N-Nitrosodimethylamine (NDMA). (Dimesky et al v. Sanofi-Aventis U.S., LLC, Sanofi US Services Inc., Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-1517, D. CT.)
Class-Action Tracker
The Latest
Fetch Awards App: Over $1 Billion in Rewards
TINA.org investigates advertised milestone.
Don’t Let a Job Training Offer TRAP You
What consumers should know about a provision hidden in some employment contracts.
KFC | THE CHICKEN TENDERS BATTLE HAS BEGUN
In the battle for the tastiest tender only one tender can prevail.
Domino’s Free Emergency Pizza
Getting a slice of this complimentary pie may be harder than you think.
How Investing in the Cutting Edge Can Bleed You Dry
What consumers should know about software tethering.